HEREDITARY ANGIOEDEMA - TYPE 2
Clinical trials for HEREDITARY ANGIOEDEMA - TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA - TYPE 2 trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA - TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for HAE patients: extension study tests long-term attack prevention
Disease control Recruiting nowThis study is for people with hereditary angioedema (HAE) who have already completed a prior phase 3 trial of ADX-324. It aims to see how safe and effective the drug is over a longer period, and whether it can reduce the number of swelling attacks. About 90 adults will receive ad…
Matched conditions: HEREDITARY ANGIOEDEMA - TYPE 2
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
Smartphone diaries reveal hidden toll of rare swelling disorder
Knowledge-focused Recruiting nowThis study aims to understand the real-life burden of hereditary angioedema (HAE) by having 30 adults with Type 1 or Type 2 HAE answer daily smartphone surveys for 8 weeks. Researchers want to see if daily tracking shows a higher and more fluctuating burden than traditional quest…
Matched conditions: HEREDITARY ANGIOEDEMA - TYPE 2
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated May 26, 2026 06:15 UTC